原发性肝癌是全球癌症相关死亡的第二大原因。目前,一旦被诊断出肝癌通常处于晚期,治疗效果一般较差。因此,迫切需要其他有效的治疗方法。巨噬细胞是肿瘤微环境的重要组成部分,巨噬细胞极化对肿瘤的增殖和分化至关重要。巨噬细胞亚型之间的调节相互作用,如M1和M2,导致许多临床结果,包括肿瘤进展和转移。所以,研究这一过程的驱动因素非常重要。长链非编码RNA已被广泛证明在肿瘤的早期诊断和治疗中具有重要价值。许多研究表明,长链非编码RNA通过其驱动M1或M2极化的能力参与巨噬细胞极化,从而参与肝癌的发生发展。在这篇文章中,我们系统地阐述了参与肝癌巨噬细胞极化的长链非编码RNA,希望能为肝癌的早期诊断和治疗提供新的思路。从PubMed检索肝癌相关研究。基于我们对LncRNA和巨噬细胞极化作为肝癌有效疗法的鉴定,我们分析了PubMed系统在过去十年中关于LncRNA和巨噬细胞极化之间的串扰的研究文章。通过靶向M1/M2巨噬细胞极化,LncRNA可能促进或抑制肝癌,参考文献主要由文章的影响因子决定。因此,探讨了LncRNA与M1/M2巨噬细胞极化的具体作用机制,随着它们在串扰发生中的作用,扩散,和肝癌转移。lncRNA在肝癌中双向表达,可以靶向巨噬细胞极化来调节肿瘤行为。lncRNA主要起ceRNA的作用,可通过细胞外囊泡参与肝癌细胞与巨噬细胞的串扰。lncRNA可能通过靶向巨噬细胞参与肝癌的免疫治疗,成为肝癌的一种新的生物分子标志物。
Primary liver cancer is the second leading cause of cancer-related death worldwide. At present, liver cancer is often in an advanced stage once diagnosed, and treatment effects are generally poor. Therefore, there is an urgent need for other powerful treatments. Macrophages are an important component of the tumor microenvironment, and macrophage polarization is crucial to tumor proliferation and differentiation. Regulatory interactions between macrophage subtypes, such as M1 and M2, lead to a number of clinical outcomes, including tumor progression and metastasis. So, it is important to study the drivers of this process. Long non-coding RNA has been widely proven to be of great value in the early diagnosis and treatment of tumors. Many studies have shown that long non-coding RNA participates in macrophage polarization through its ability to drive M1 or M2 polarization, thereby participating in the occurrence and development of liver cancer. In this article, we systematically elaborated on the long non-coding RNAs involved in the polarization of liver cancer macrophages, hoping to provide a new idea for the early diagnosis and treatment of liver cancer. Liver cancer- related studies were retrieved from PubMed. Based on our identification of LncRNA and macrophage polarization as powerful therapies for liver cancer, we analyzed research articles in the PubMed system in the last ten years on the crosstalk between LncRNA and macrophage polarization. By targeting M1/M2 macrophage polarization, LncRNA may promote or suppress liver cancer, and the references are determined primarily by the article\'s impact factor. Consequently, the specific mechanism of action between LncRNA and M1/M2 macrophage polarization was explored, along with the role of their crosstalk in the occurrence, proliferation, and metastasis of liver cancer. lncRNA is bidirectionally expressed in liver cancer and can target macrophage polarization to regulate tumor behavior. lncRNA mainly functions as ceRNA and can participate in the crosstalk between liver cancer cells and macrophages through extracellular vesicles. lncRNA can potentially participate in the immunotherapy of liver cancer by targeting macrophages and becoming a new biomolecular marker of liver cancer.